New insulin glargine 300 U/ml versus glargine 100 U/ml in Japanese adults with type 1 diabetes using basal and mealtime insulin: glucose control and hypoglycaemia in a randomized controlled trial (EDITION JP 1)

Author:

Matsuhisa M.1,Koyama M.2,Cheng X.3,Takahashi Y.2,Riddle M. C.4,Bolli G. B.5,Hirose T.6,

Affiliation:

1. Tokushima University; Tokushima Japan

2. Sanofi; Tokyo Japan

3. Sanofi; Beijing China

4. Oregon Health & Science University; Portland OR USA

5. Perugia University Medical School; Perugia Italy

6. Toho University School of Medicine; Tokyo Japan

Funder

Sanofi

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference28 articles.

1. Standards of medical care in diabetes - 2015. 7. Approaches to glycemic treatment;American Diabetes Association;Diabetes Care,2015

2. Type 1 diabetes;Atkinson;Lancet,2014

3. Japan Diabetes Society Treatment guide for diabetes 2013 2012 2013

4. Recent product approvals in Japan;Inpharma Weekly,2003

5. Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN study 1.2);Kanazawa;Endocr J,2007

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3